6 New Medications for Rheumatology in 2018

December 21, 2018

Here’s a brief look at 6 medications for rheumatologic disorders that were newly approved in the second half of 2018.

Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis Gets FDA Nod

October 17, 2018

The approval is based on data from two randomized, sham injection-controlled, double-masked phase 3 clinical trials with patient follow-up for 3 years.

ACR 2018 Preview: A Look at What’s New in Rheumatology

October 16, 2018

Here: highlights of some of the studies that will be presented at the American College of Rheumatology 2018 Annual Meeting in Chicago from October 19 to 24.

Uveitis Patient Selection Key for Adalimumab Treatment

September 28, 2016

Adalimumab for the treatment of noninfectious uveitis has advantages over no treatment or conventional treatment with steroid therapy.

Adalimumab Approved for Uveitis

July 07, 2016

In this story, we revisit the clinical trials that led to the approval of adalimumab for uveitis.

Babesiosis in a Patient With Corticosteroid-Resistant Uveitis

August 29, 2012

The tumor necrosis factor α antagonist infliximab has been used for treating patients with uveitis resistant to corticosteroids.